Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Samaritan Pharmaceuticals has signed an exclusive distribution agreement for the territory of Greece and Cyprus with Eusa Pharma for two drugs, Erwinase and Kidrolase.
Subscribe to our email newsletter
Erwinase and Kidrolase are oncology drugs used in the treatment of acute lymphoblastic leukemia.
Janet Greeson, CEO of Samaritan, said: “We are always enthusiastic about growing our marketing and sales arm and increasing our sales revenues and think Erwinase and Kidrolase can play an important role as much needed cancer drugs in Samaritan’s strategy to become cash flow positive by 2009.